Luseogliflozin
Luseogliflozin (trade name Lusefi) is a pharmaceutical drug (an SGLT2 inhibitor) used for the treatment of type 2 diabetes mellitus. It was approved for use in Japan in 2014.
Wikipage redirect
Link from a Wikipage to another Wikipage
primaryTopic
Luseogliflozin
Luseogliflozin (trade name Lusefi) is a pharmaceutical drug (an SGLT2 inhibitor) used for the treatment of type 2 diabetes mellitus. It was approved for use in Japan in 2014.
has abstract
Luseogliflozin (trade name Lus ...... oved for use in Japan in 2014.
@en
alternative name
Lusefi
@en
CAS number
898537-18-3
DrugBank
FDA UNII code
C596HWF74Z
PubChem
Wikipage page ID
58,772,236
page length (characters) of wiki page
Wikipage revision ID
998,040,118
Link from a Wikipage to another Wikipage
ATC prefix
A10
@en
ATC suffix
BK07
@en
CAS number
DrugBank
DB12214
@en
legal status
Rx-only in Japan
@en
PubChem
11,988,953
SMILES
CCOC1=CC=CCC2=CC
@en
synonyms
TS-071
@en
tradename
Lusefi
@en
UNII
C596HWF74Z
@en
wikiPageUsesTemplate
comment
Luseogliflozin (trade name Lus ...... oved for use in Japan in 2014.
@en
label
Luseogliflozin
@en